ArticleJornal brasileiro de nefrologia
Prevention is less expensive than treatment in chronic kidney disease: a descriptive analysis.
Article in Jornal brasileiro de nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effects of a 12-Week Multidisciplinary Program on Health-Related Physical Fitness and Depressive Symptoms in Overweight and Obese Women Aged Between 45 and 64 Years with Noncommunicable Chronic Diseases.International journal of environmental research and public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe prevalence of chronic kidney disease (CKD) is increasing worldwide, leading to great concern regarding costs, particularly in underdeveloped or developing countries. Estimating the costs of different CKD management approaches is necessary for planning public policies.
objectivesTo evaluate the costs of renal replacement therapy (RRT) and non-RRT treatment and to propose the screening for CKD in the Brazilian Health Care System (SUS).
methodsThis descriptive analysis was based on information from the Brazilian Health Ministry database, DATASUS (www.datasus.saude.gov.br), and scheduled payments approved by the SUS, including complementary exams related to CKD screening, diagnosis and treatment, recommended assessments by stages of CKD, and health professionals' salaries.
resultsValues (in US$) of the probable annual costs for CKD since diagnosis, followed by different CKD stages, and the RRT phase are: first evaluation, 5.00; first evaluation of individuals at risk, 12.03; CKD stage 1, 5.00; 2, 7.36; 3, 53.32; 3B, 36.85; 4, 129.51; 5-non dialytic, 183.73; 5D-peritoneal dialysis, 3,539.10; and stage 5D-hemodialysis (7,925.87).
conclusionThe cost of screening (early diagnosis) for CKD or initial assessment of CKD stage 1 for one patient, including complementary exams and medical appointments, is US$ 5.00 (based on standard SUS reimbursement values). The costs of 1 year of treatment for a single patient with stage 5D CKD on hemodialysis could cover care for 1,584 with stage 1 CKD or 61 patients with stage 4 CKD. Our data indicates a clear economic advantage of early CKD diagnosis for public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.